Share Twitter LinkedIn Facebook Email Shouryadeep Srivastava, MBBS, PhD of @TakedaOncology discusses CML patients prescribed ponatinib vs bosutinib: what is next for research?
Asciminib: ASH 2022 Prof. Tim Hughes Studies For patients With CML Chronic Myelogenous Leukemia 7 Mins Read
